Thanks to our incredible users and collaborators, the last two years at Alipheron have been packed with innovation. Today, we’re pleased to unveil the Alipheron End-to-End Search Platform - built to make analogue compound searching for drug discovery faster, more precise, and incredibly scalable.
...
Alipheron has had a busy first half of the year attending many productive events.
We attended the BMCS 3rd Conformational Design in Drug Discovery 2026 meeting on the GSK campus in Stevenage (UK), followed by the Symposium on AI-Driven Small-Molecule Drug Discovery in Barcelona, and the ACS Spring 2026 National Meeting in Atlanta.
...
The first half of 2026 has seen quite a few new and updated spaces on the Alipheron Search Platform.
We added the XtalPi VAST space with about 5 billion compounds and the Otava ChemInfinita space with 800 billion compounds.
...
Pharos3D can now accept as input, multiple fragments oriented in a bioactive configuration relative to each other and return single-molecule solutions to this boundary value problem.
...